CNTA
Featured PickCentessa Pharmaceuticals plc
Real picks. Real tracking. We bet on one stock daily and show you exactly how it plays out.
AI Confidence Score
85
Entry Price
$39.80
Current Price
$35.57
Total Return
+0.00%
vs SPY
+0.00%
As of Close 2026-06-04
Executive Summary
Centessa Pharmaceuticals (CNTA) has secured a fresh fundamental catalyst today, receiving FDA Orphan Drug Designation for cleminorexton in the treatment of idiopathic hypersomnia. This regulatory milestone injects immediate upside momentum into a stock already technically primed for a breakout. In a broader market regime characterized by RISK_ON behavior where high-beta momentum plays are actively rewarded despite geopolitical noise, CNTA perfectly fits the profile of a resilient outperformer. The confluence of a powerful fundamental driver and a technically pristine setup makes this a high-conviction momentum play.
Technical Context
Setup
The stock is flashing top-tier ALPHA_MALE and QUIET_STORM signals, trading just -0.3% below its 52-week high with healthy volume confirmation at 1.7x its 20-day average.
Invalidation (Stop)
The bullish thesis is invalidated if the stock breaks and closes below the established support level of $39.58.
Runner-ups
Recent Performance History
81 Total Picks • 48% Win Rate (7d)
| Date | Ticker | Entry | Last | Gain/Loss | 7d | 30d | 60d |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | STM | $79.71 | $78.36 | -1.69% | N/A | N/A | N/A |
| 2026-06-02 | STM | $79.51 | $78.36 | -1.45% | N/A | N/A | N/A |
| 2026-05-29 | CMBT | $15.47 | $14.44 | -6.66% | N/A | N/A | N/A |
| 2026-05-27 | CVLG | $39.59 | $43.22 | +9.17% | +6.49% | N/A | N/A |
| 2026-05-22 | PKBK | $31.49 | $30.85 | -2.03% | -2.41% | N/A | N/A |
| 2026-05-21 | BAP | $344.00 | $326.53 | -5.08% | -0.73% | N/A | N/A |
| 2026-05-20 | CMBT | $17.26 | $14.44 | -16.34% | -8.75% | N/A | N/A |
| 2026-05-19 | CMBT | $16.61 | $14.44 | -13.06% | -1.14% | N/A | N/A |
| 2026-05-18 | BAP | $303.86 | $326.53 | +7.46% | +15.76% | N/A | N/A |
| 2026-05-15 | BAP | $316.31 | $326.53 | +3.23% | +5.69% | N/A | N/A |
Schema v1.0 | Pipeline v1.2.0